Document Detail

Effects of intravenous endralazine in essential hypertension.
MedLine Citation:
PMID:  6349669     Owner:  NLM     Status:  MEDLINE    
The effects of endralazine, administered intravenously, on blood pressure, heart rate, forearm blood flow, plasma renin activity, aldosterone, adrenaline and noradrenaline were studied in five patients with essential hypertension. Endralazine reduced peripheral vascular resistance, resulting in decrease in mean arterial pressure from 141 to 116 mm Hg and increase in heart rate from 67 to 92 beats/min. Plasma renin activity, adrenaline and noradrenaline increased significantly after endralazine infusion. All effects observed are consistent with endralazine acting as a peripheral vasodilating drug.
J J Hoffmann; T Thien; A van T'Laar
Related Documents :
6187789 - Evaluation of a long-acting converting enzyme inhibitor (enalapril) for the treatment o...
1477169 - Species-specific kinetics of mouse renin contribute to maintenance of normal blood pres...
8960499 - Idiopathic arterial calcification of infancy: effectiveness of prostaglandin infusion f...
232019 - Effects of an angiotensin converting enzyme inhibitor on psychosocial hypertension in m...
3005169 - Renal and endocrine response to saline infusion in essential hypertension.
7040889 - Renin release by pentobarbital anesthesia in the rat: a role for vascular mechanisms.
2961689 - Impaired control of vasopressin release in hypertensive subjects with cardiac hypertrophy.
20710069 - Differential pressure measurement using a free-flying insect-like ornithopter with an m...
11794649 - Determination of the critical pressure drop for filtration of super-compactible cakes.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  British journal of clinical pharmacology     Volume:  16     ISSN:  0306-5251     ISO Abbreviation:  Br J Clin Pharmacol     Publication Date:  1983 Jul 
Date Detail:
Created Date:  1983-10-08     Completed Date:  1983-10-08     Revised Date:  2009-11-18    
Medline Journal Info:
Nlm Unique ID:  7503323     Medline TA:  Br J Clin Pharmacol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  39-44     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Aldosterone / blood
Antihypertensive Agents / administration & dosage*,  adverse effects
Blood Pressure / drug effects
Epinephrine / blood
Hypertension / drug therapy*
Middle Aged
Norepinephrine / blood
Pyridazines / administration & dosage*,  adverse effects
Renin / blood
Time Factors
Reg. No./Substance:
0/Antihypertensive Agents; 0/Pyridazines; 39715-02-1/BQ 22-708; 51-41-2/Norepinephrine; 51-43-4/Epinephrine; 52-39-1/Aldosterone; EC

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A dose ranging study of atenolol in hypertension: fall in blood pressure and plasma renin activity, ...
Next Document:  Structure and function of the Ca antigen.